1. Home
  2. TNC vs EVO Comparison

TNC vs EVO Comparison

Compare TNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$75.31

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
EVO
Founded
1870
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TNC
EVO
Price
$75.31
$3.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$113.50
$7.00
AVG Volume (30 Days)
152.8K
259.6K
Earning Date
11-03-2025
11-05-2025
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
2.91
N/A
Revenue
$1,240,800,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.63
$8.52
P/E Ratio
$25.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$67.32
$2.84
52 Week High
$90.44
$5.10

Technical Indicators

Market Signals
Indicator
TNC
EVO
Relative Strength Index (RSI) 51.68 50.69
Support Level $73.77 $2.87
Resistance Level $75.90 $3.05
Average True Range (ATR) 1.70 0.10
MACD 0.12 0.03
Stochastic Oscillator 47.83 72.97

Price Performance

Historical Comparison
TNC
EVO

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: